NATCO PHARMA LIMITED (INDIA)
Cabazitaxel-kabanat
"Cabazitaxel" is the Drug / Molecule content in “Kabanat”. Cabazitaxel is a microtubule inhibitor.it binds to tubulin and promotesits assembly into microtubules while simultaneously inhibiting disassembly.This leads to the stabilization of microtubules,which result in the inhibition of mitotic andinterphase cellular functions.
Indication
"Kabanat" is a microtubule inhibitor indicated in combination with prednisone for the treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel containing treatment regimen.
Note
Precaution
- Kabanat is a prescription drug and should be used under proper medical guidance and advice.
- Avoid drinking grape fruit juice or eating grape fruit.
Strength
60 mg
Packing
Vial
Storage
Store at room Temperature (25 C).